Determinants of erlotinib and pemetrexed synergism in non-small cell lung cancer (NSCLC) cell lines

Giovannetti E, Smid K, Tekle C, Mey V, Rodriguez JA, Nannizzi S, Del Tacca M, Danesi R, Giaccone G, Peters GJ

Presentation on “erlotinib-pemetrexed synergisms” at the Targeted Anticancer Agents (TAT) Meeting 2007

VUMC, Amsterdam, The Netherlands
University of Pisa, Italy

International Symposium on Targeted Anticancer Therapies (TAT 2007)
Amsterdam, 7/10 March 2007

Pdf: TAT2007